One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The trial to assess chelation therapy 2 (TACT2): Rationale and design
Gervasio A. Lamas, MD a , Kevin J. Anstrom, PhD b , Ana Navas-Acien, MD, PhD c , Robin Boineau, MD, MA d , Hwasoon Kim, PhD e , Yves Rosenberg, MD f , Mario Stylianou, PhD f , Teresa L.Z. Jones, MD g , Bonnie R. Joubert, PhD h , Regina M. Santella, PhD c , Esteban Escolar, MD a , Y. Wady Aude, MD i , Vivian Fonseca, MD j , Thomas Elliott, MBBS k , Eldrin F. Lewis, MD, MPH l , Michael E. Farkouh, MD, MSc m , David M. Nathan, MD n , Ana C. Mon, MPH a , Leigh Gosnell e , Jonathan D. Newman, MD, MPH o , and Daniel B. Mark, MD, MPH e , for the TACT2 Investigators , Miami Beach, FL, Chapel Hill, NC, New York, NY, Bethesda, MD, Durham, NC, McAllen, TX, New Orleans, LA, Vancouver, BC, Palo Alto, CA, Boston, MA, New York, NY
doi : 10.1016/j.ahj.2022.05.013
Volume 252, October 2022, Pages 1-11
Intravenous edetate disodium-based infusions reduced cardiovascular events in a prior clinical trial. The Trial to Assess Chelation Therapy 2 (TACT2) will replicate the initial study design.
Design and rationale of the mobile health intervention for rural atrial fibrillation
Jared W. Magnani, MD, MSc a,b , Danielle Ferry, MA a , Gretchen Swabe, MS a , Deborah Martin, BA b , Xirun Chen, MPH b , Maria M. Brooks, PhD b , Everlyne Kimani, PhD c , Michael K. Paasche-Orlow, MD, MA, MPH d , Stefán Ólafsson, PhD c,e , Timothy Bickmore, PhD c , and Samar R. El Khoudary, PhD, MPH b Pittsburgh, PA; Boston, MA
doi : 10.1016/j.ahj.2022.05.023
Volume 252, October 2022, Pages 16-25
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial
Damian Maganja, MIPH a , Kathy Trieu, PhD a , Michelle Reading, BSc a , Liping Huang, PhD a , Ashleigh Chanel Hart, MPH a , Fraser Taylor, MEng a , Steve Stamatellis, BAppSc a , Clare Arnott, PhD a,b , Xiaoqi Feng, PhD a,c , Aletta E Schutte, PhD a,c , Gian Luca Di Tanna, PhD a , Cliona Ni Mhurchu, PhD a,d , Adrian J Cameron, PhD e , Mark D Huffman, MD a,f , Bruce Neal, PhD a,g , and Jason HY Wu, PhD a New South Wales, Australia; Auckland, New Zealand; Victoria, Australia; St. Louis, MO; London, United Kingdom
doi : 10.1016/j.ahj.2022.06.007
Volume 252, October 2022, Pages 70-83
Select drug-drug interactions with colchicine and cardiovascular medications: A review
Dave L. Dixon, PharmD a , Jaideep Patel, MD b,c , Rowan Spence, PharmD a , Azita H. Talasaz, PharmD a , Antonio Abbate, MD, PhD e , and Barbara S. Wiggins, PharmD d Richmond, VA; Charleston, SC
doi : 10.1016/j.ahj.2022.06.002
Volume 252, October 2022, Pages 42-50
Risk factors and outcomes of sudden cardiac arrest in pediatric heart transplant recipients
Seth A. Hollander, MD a , Lynsey Barkoff, NP b , Heather Giacone, MD a , Greg T. Adamson, MD a , Beth D. Kaufman, MD a , Kara S. Motonaga, MD a , Anne M. Dubin, MD a , and Henry Chubb, MBBS, PhD a Palo Alto, California, USA
doi : 10.1016/j.ahj.2022.06.003
Volume 252, October 2022, Pages 31-38
Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography
Reza Mohebi, MD a,b , Cian P. McCarthy, MB, BCh, BAO a,b , Hanna K. Gaggin, MD, MPH a,b , Roland R.J. van Kimmenade, MD, PhD c , and James L. Januzzi, MD a,b,d Boston, MA; Nijmegen, the Netherlands
doi : 10.1016/j.ahj.2022.06.004
Volume 252, October 2022, Pages 51-59
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey
Abdul Mannan Khan Minhas, MD a , Sardar Hassan Ijaz, MD b , Nismat Javed, MBBS c , Abu Baker Sheikh, MD d , Vardhmaan Jain e , Erin D. Michos, MD, MHS f , Stephen J. Greene, MD g,h , Marat Fudim, MD, MHS g,h , Haider J. Warraich, MD i , Michael D. Shapiro, DO, MCR j , Sadeer G. Al-Kindi, MD k , Laurence Sperling, MD l , and Salim S. Virani, MD, PhD m Hattiesburg, MS; Burlington, MA; Islamabad, Pakistan; Albuquerque, NM; Cleveland, OH; Baltimore, MD; Durham, NC; Boston, MA
doi : 10.1016/j.ahj.2022.05.015
Volume 252, October 2022, Pages 60-69
Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial
Jonathan D. Newman, MD, MPH, Pamela S. Douglas, MD, Ilya Zhbannikov, PhD, Maros Ferencik, MD, PhD, MCR, Borek Foldyna, MD, Udo Hoffmann, MD, MPH, Svati H. Shah, MD, MHS, Geoffrey S. Ginsburg, MD, PhD, Michael T. Lu, MD, MPH# , and Deepak Voora, MD# New York, NY
doi : 10.1016/j.ahj.2022.05.012
Volume 252, October 2022, Pages 12-15
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction—1-year follow-up results of the COMPARE CRUSH trial
Rosanne F. Vogel, MD a,b , Ronak Delewi, MD, PhD b , Jeroen M. Wilschut, MD c , Miguel E. Lemmert, MD, PhD c,d , Roberto Diletti, MD, PhD c , Ria van Vliet, BSc e , Nancy W.P.L. van der Waarden, MSc f , Rutger-Jan Nuis, MD, PhD c , Valeria Paradies, MD e , Dimitrios Alexopoulos, MD, PhD g , Felix Zijlstra, MD, PhD c , Gilles Montalescot, MD, PhD h , Dominick J. Angiolillo, MD, PhD i , Mitchell W. Krucoff, MD, PhD j , Pieter C. Smits, MD, PhD e , Nicolas M. Van Mieghem, MD, PhD c , and Georgios J. Vlachojannis, MD, PhD a,e Amsterdam, The Netherlands; Utrecht, The Netherlands; Rotterdam, The Netherlands; Zwolle, The Netherlands; Rotterdam, The Netherlands; Barendrecht, The Netherlands; Athens, Greece; Paris, France; Jacksonville, FL; Durham, NC
doi : 10.1016/j.ahj.2022.05.022
Volume 252, October 2022, Pages 26-30
Statin-associated muscle symptoms in the VITamin D and OmegA-3 TriaL (VITAL)
Pedro Engel Gonzalez, MD a , Mark A. Hlatky, MD b , JoAnn E. Manson, MD, DrPH c,d , Julie E. Buring, ScD c,d , I-Min Lee, MBBS, ScD c,d , Nancy R. Cook, ScD c,d , Vadim Bubes, PhD c , and Neil J. Stone, MD a Chicago, IL; Stanford, CA; Boston, MA
doi : 10.1016/j.ahj.2022.06.001
Volume 252, October 2022, Pages 39-41
